News & Updates

Despite having no such history, about a third of patients with Parkinson’s disease (PD) show evidence of thrombocytopaenia or platelet dysfunction, reports a recent study.

In Japan, the declaration of a state of emergency in response to the COVID-19 pandemic led to negative metabolic consequences in people with glucose intolerance, such as lowered skeletal muscle and increased body weight and body fat, a recent study has found.

In patients with metastatic colorectal cancer (mCRC), using trifluridine/tipiracil with bevacizumab is a safe and effective treatment for refractory disease, a recent study has found.

Individuals exposed to low-dose methotrexate risk developing melanoma, although the absolute risk increase remains very low, as shown in a recent meta-analysis.

Circulating cathepsin S (CTSS) is significantly associated with long-term mortality and may be used to enhance risk stratification of patients with non–ST-segment elevation acute coronary syndrome (NSTE-ACS) over the Global Registry of Acute Coronary Events (GRACE) risk score, suggests a study.

Most adults with d-loop transposition of the great arteries (d-TGA) after atrial switch operation exhibit slow progression to end-stage heart failure or death, according to a recent study.

Gastric cancer (GC) patients show an altered metabolic profile as compared with healthy individuals, a recent China study has found. A biomarker panel monitoring for nine metabolites can facilitate timely detection of GC.

First-line treatment of ALK-positive non-small-cell lung cancer (NSCLC) with lorlatinib improves progression-free survival (PFS) and reduces central nervous system (CNS) progression vs crizotinib, regardless of presence or absence of baseline brain metastases (BM), a post hoc analysis of the phase III CROWN trial has shown.